Complete Response to Afatinib in Lung Adenocarcinoma of Epidermal Growth Factor Receptor Exon-19 Deletion Mutation and Disease Recurrence on Drug Discontinuation. Issue 4 (December 2018) - Kumari, Rashmi; James, Emmanuel; Pavithran, K.